A great deal of confusion and uncertainty over genotoxic impurity
(GTI) identification, assessment, and control exists in the
pharmaceutical industry today. Pharmaceutical Industry
Practices on Genotoxic Impurities strives to facilitate
scientific and systematic consensus on GTI management by
presenting rationales, strategies, methods, interpretations,
practices, and case studies from the pharmaceutical industry.
Featuring the... more...